Lenex provided structural and heavy steel fabrication for Andelyn Biosciences’ cutting-edge clinical manufacturing facility that produces materials for phase 1, 2, and 3 gene therapy clinical studies. Serving biotechnology and pharmaceutical industries worldwide, this facility plays a critical role in advancing gene therapy treatments. Lenex’s contribution ensured the structural integrity and precision required for such a highly specialized project.
